Occuity is committed to tackling healthcare challenges that affect a billion people worldwide. If you're interested in joining our mission but would like to know more, we've compiled a list of answers to common questions about the Occuity Crowdfunding process.
Why should I invest in the Occuity Crowdfunding campaign?
Occuity is developing revolutionary devices that aim to provide a better solution to chronic health challenges that affect a billion people worldwide. Our optical devices intend to make instant, diagnostic health information easily accessible for the millions of people who struggle daily with painful invasive tests. By investing, you will become a shareholder in our company, and join our journey.
What are the risks?
As with all investments your capital is at risk. Please read the Risk Warnings before investing. Investments should only be made by investors who understand these risks. One benefit of crowdfunding however is that there is a lower barrier of entry as you do not need to have access to a large amount of capital to begin investing. With our campaign you can become an equity holder with one share valued at £15.70.
What is the minimum and maximum I can invest?
In the Occuity Crowdfunding campaign you can invest as little as £15.70 with no upper limit.
The more investment we raise, the faster we can deliver our innovative devices into the hands of people around the world. Even if you hold one share valued at £15.70 you are still making a massive difference in our mission to tackle common health challenges, so no contribution is too small.
Can I invest a small amount?
Absolutely. We accept investments from £15.70, which is very palatable for most investors – the equivalent of 5 cups of coffee! There is no pressure to invest high amounts of capital, how much you choose to invest is entirely up to you.
What will my money be used for?
Your money will be used to help accelerate the research & development of our revolutionary, non-contacting, optical devices that help screen and monitor common diseases that affect a billion people worldwide. For the Occuity glucose monitor, the roadmap involves prototype production, clinical trials, and regulatory approval. Other patented products in the pipeline include a device for Alzheimer’s disease screening and the PM1 Pachymeter for ophthalmologists to measure corneal thickness. Once each product is available to the market, we plan to use the revenue generated to further accelerate other products under the Occuity brand.
Can I sell my shares?
Yes, this is possible on Seedrs. All investors who hold their shares through Seedrs may be able to utilise the Seedrs Secondary market to buy and sell shares of businesses on the platform. Please refer to Seedrs Secondary Market for more information.
Are Seedrs Investments safe?
Our investment campaign operates on the platform Seedrs, who is authorised by the Financial Conduct Authority (FCA) in the UK to act as an equity crowdfunding platform. The FCA aims to protect investors and the integrity of the UK financial system by establishing best practices and regulations for all financial service businesses. Please visit fca.org.uk for more information.
What is the Seedrs secondary market?
The Seedrs Secondary Market provides investors the opportunity to sell their investments to other buyers on the platform. . More information on Seedrs secondary market can be found here.
Who can buy Occuity shares?
Anyone can buy shares, but we are primarily interested in finding supporters who believe in our mission of alleviating some of humanity’s greatest healthcare challenges. All contributions, no matter how little, will have a huge impact on our business. Many people have friends or family who live with diabetes, and it would be a great benefit to them and us if you helped share awareness of the Occuity Crowdfunding campaign.
You will need to open an account on Seedrs and become authorised to invest in order to join our journey. This is usually a quick process, and will involve some identity checks as well as some straightforward questions about the risks associated with investing in early-stage businesses.
Is this an EIS approved investment?
This crowdfunding round is EIS eligible, meaning tax relief could be available to investors, depending on their personal circumstances. The EIS (Enterprise Investment Scheme) is a UK government scheme designed to help early-stage trading companies attract funding. To learn more about the income tax and capital gains tax reliefs you could be eligible for, please click here.
Investing involves risks, including loss of capital, illiquidity, lack of dividends and dilution, and should be done only as part of a diversified portfolio. This article has been approved as a financial promotion by Seedrs Limited, which is authorised and regulated by the Financial Conduct Authority (No. 550317). Not all shares will be eligible for the Secondary Market and, even if they are, the ability to buy and sell shares will depend on demand. It can be difficult to find a buyer or seller, and investors should not assume that an early exit will be available just because a secondary market exists. Tax treatment depends on individual circumstances and is subject to change in future.